Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
3.450
-0.070 (-1.99%)
At close: May 15, 2026, 4:00 PM EDT
3.440
-0.010 (-0.29%)
After-hours: May 15, 2026, 7:57 PM EDT

Iovance Biotherapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-353.86-390.98-372.18-444.04-395.89-342.25
Depreciation & Amortization
46.5947.3248.0733.1321.1413.98
Stock-Based Compensation
49.9361.58109.6362.6384.0269.77
Other Adjustments
4.383.94-11.48-7.010.876.01
Change in Receivables
-10.82-13.11-69.19-0.15--
Changes in Inventories
-5.31-14.21-44.38---
Changes in Accounts Payable
7.18-6.66-7.844.835.886.98
Changes in Accrued Expenses
5.3528.648.5819.77-4.720.68
Changes in Other Operating Activities
-15.27-18.14-14.19-20.86-4.07-3.11
Operating Cash Flow
-270.79-302.41-352.98-361.82-292.76-227.94
Capital Expenditures
-34.23-33.84-11.07-22.29-20.43-37.57
Purchases of Investments
-276.74-318.67-460.77-205.9-245.82-725.21
Proceeds from Sale of Investments
354400428285.58522.7762.91
Payments for Business Acquisitions
---52.57-212.63--
Investing Cash Flow
43.0247.5-96.41-155.24256.460.13
Long-Term Debt Issued
-----1
Net Long-Term Debt Issued (Repaid)
-----1
Issuance of Common Stock
201.28307.83403.52465.75192.8238.27
Repurchase of Common Stock
-5.59-7.06-12.86-2.8-2.65-
Net Common Stock Issued (Repurchased)
195.68300.77390.66462.96190.15238.27
Financing Cash Flow
251.79300.77390.66462.96190.15239.27
Effect of Exchange Rate Changes on Cash and Cash Equivalents
0.421.14-0.54-2.74--
Net Cash Flow
24.4547.01-59.27-56.84153.8511.46
Free Cash Flow
-305.02-336.24-364.05-384.11-313.18-265.52
FCF Margin
-106.80%-127.61%-221.89%-32305.30%--
Free Cash Flow Per Share
-0.80-0.94-1.26-1.63-1.97-1.73
Levered Free Cash Flow
-349.56-387.87-393.01-429.45-398.08-340.29
Unlevered Free Cash Flow
-357.96-398.12-413.13-442.4-401.06-341.74
Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q